Using a rate-frequency curve method to assess the rewarding properties of morphine in the intracranial self-stimulation paradigm in rats

Journal of Neuroscience Methods

Volumn 189, Issue 1, 2010, Pages 75-79

  O'Neill, Krystal S ^a   Todtenkopf, Mark S ^a  

^a ALKERMES INC   (United States)

Author keywords

Brain stimulation reward; Drug abuse; ICSS; Morphine; Rate frequency curve; Sedative; Self stimulation

Indexed keywords

ALCOHOL; MORPHINE;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DRUG ABUSE; HYPOTHALAMUS; MALE; MORPHINE ADDICTION; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD; SEDATION; SELF STIMULATION; STIMULUS RESPONSE;

ANIMALS; ARTIFACTS; CONDITIONING, OPERANT; CONSCIOUS SEDATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; ETHOLOGY; HYPNOTICS AND SEDATIVES; MALE; MORPHINE; MOTOR ACTIVITY; NARCOTICS; NEUROPHARMACOLOGY; NEUROPSYCHOLOGY; RATS; RATS, WISTAR; REINFORCEMENT (PSYCHOLOGY); REWARD; SELF STIMULATION;

EID: 77952550262     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2010.03.009     Document Type: Article

References (17)

1. Cadoni C., Di Chiara G. Differences in dopamine responsiveness to drugs of abuse in the nucleus accumbens shell and core of Lewis and Fischer 344 rats. J Neurochem 2007, 103:487-499.
2. Carlezon W.A. Place conditioning to study reward and aversion. Opioid research: methods and protocols 2003, 243-249. Humana Press, Totowa, NJ. Z.Z. Pan (Ed.).
3. Carlezon W.A., Wise R.A. Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801. Brain Res 1993, 620:339-342.
4. Cunningham C.L., Gremel C.M., Groblewski P.A. Drug-induced conditioned place preference and aversion in mice. Nat Protoc 2006, 1:1662-1670.
5. Do Carmo G.P., Stevenson G.W., Carlezon W.A., Negus S.S. Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: further studies on pain-depressed behavior. Pain 2009, 144:170-177.
6. Easterling K.W., Plovnick R.M., Holtzman S.G. Acute opioid but not benzodiazepine dependence in rats responding for intracranial self-stimulation. Psychopharmacology (Berl) 2000, 148:263-271.
7. Hand T.H., Franklin K.B. Associative factors in the effects of morphine on self-stimulation. Psychopharmacology (Berl) 1986, 88:472-479.
8. Hubner C.B., Kornetsky C. Heroin, 6-acetylmorphine and morphine effects on threshold for rewarding and aversive brain stimulation. J Pharmacol Exp Ther 1992, 260:562-567.
9. Kornetsky C., Esposito R.U., McLean S., Jacobson J.O. Intracranial self-stimulation thresholds: a model for the hedonic effects of drugs of abuse. Arch Gen Psychiatry 1979, 36:289-292.
10. National Research Council Guide for the care and use of laboratory animals 1996, National Academy Press, Washington, DC. 7th ed.
11. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2005, Elsevier Academic Press. 5th ed.
12. Reid L.D. Tests involving pressing for intracranial stimulation as an early procedure for screening likelihood of addiction of opioids and other drugs. Methods of assessing the reinforcing properties of abused drugs 1987, 391-410. Springer-Verlag, New York. M.A. Bozarth (Ed.).
13. Stellar J.R., Rice M. Pharmacological basis of intracranial self-stimulation reward. Neuropharmacological basis of reward 1989, 15-65. Oxford Press, New York. J.M. Lieberman, S.J. Cooper (Eds.).
14. Todtenkopf M.S., Carlezon W.A. Contribution of drug doses and conditioning periods to psychomotor stimulant sensitization. Psychopharmacology (Berl) 2006, 185:451-458.
15. Todtenkopf M.S., O'Neill K.S., Kriksciukaite K., Turncliff R.Z., Dean R.L., Ostrovsky-Day I., et al. Route of administration affects the ability of naltrexone to reduce amphetamine-potentiated brain stimulation reward in rats. Addict Biol 2009, 14:408-418.
16. Wise R.A. Drug-activation of brain reward pathways. Drug Alcohol Depend 1998, 51:13-22.
17. Xi Z.-X., Spiller K., Pak A.C., Gilbert J., Dillon C., Li X., et al. Cannabinoid CB1 receptor antagonists attenuate Cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Neuropsychopharmacology 2008, 33:1735-1745.